Home › Biogen Rises on Data From Early-Stage Alzheimer's Drug Trial
 

Keywords :   


Biogen Rises on Data From Early-Stage Alzheimer's Drug Trial

2014-12-03 00:11:59| Agriculture - Topix.net

Biogen Idec Inc. shares rose after the company said its Alzheimer's drug showed promising early results and will be quickly moved into a final-stage trial. In a small, early stage trial, Biogen's drug BIIB037 reduced beta amyloid in the brain, said Doug Williams, executive vice president of research and development, at a Deutsche Bank conference in Boston today.

Tags: data trial drug rises

Category:Agriculture and Forestry

Latest from this category

All news
26.06Now is not the time for African swine fever fatigue
26.06Pork producers lead coalition against sprinkler mandate
26.06Farm Progress America, June 26, 2024
26.06Strategic use of soybean meal to maximize hog carcass weight during summer
25.06Water requirements in the summer
25.06New model Is transforming the study of liver abscesses in cattle
25.06DNA Genetics opens new commercial sow research farm
25.06Midwest swine herds report increase in PRRSV variant
Agriculture and Forestry »
26.06Disruption as airline pilots begin industrial action
26.06Atlantic Tropical Weather Outlook
26.06Eastern North Pacific Tropical Weather Outlook
26.06Now is not the time for African swine fever fatigue
26.06Ex-BHS director must pay 50m over firm's collapse
26.06WEG Mexico Obtains Quality Certificate from QUALICOAT
26.06Pork producers lead coalition against sprinkler mandate
26.06Cool Roof Coatings Market to Reach US$9.2B by 2030: Fairfield
More »